ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Order Full text via Infotrieve
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Summers, Q.
Right arrow Articles by Holgate, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Summers, Q.
Right arrow Articles by Holgate, S.
Eur Respir J 1992; 5: 313-317
Copyright © ERS Journals Ltd 1992


Original Articles

Bronchial reactivity to histamine and bradykinin is unchanged after rhinovirus infection in normal subjects

QA Summers, PG Higgins, IG Barrow, DA Tyrrell, and ST Holgate

We investigated the effects of rhinovirus (RV) infection on airways reactivity. Twenty seven normal volunteers (11 atopic) were inoculated with RV 2 or RV EL. The provocative concentrations of histamine and bradykinin required to produce a 15% fall in the forced expiratory volume in one second (FEV1) (PC15FEV1) were measured before, 7 and 21 days after inoculation. Infection was determined by a fourfold rise in anti-viral antibody titre and by viral culture from nasal washings. Peak expiratory flow rate (PEF) was recorded three days before and for 21 days after inoculation. All subjects underwent the first two bronchial challenges, and 22 the third challenge. For the whole group and for atopic subjects, there were significant correlations between the PC15 values for bradykinin and histamine (r = 0.82 and r = 0.85, respectively). Twenty subjects were infected; six had clinical colds. For the 16 infected subjects who had all three challenges, the median (range) PC15FEV1 for the histamine challenges was 36 (0.89-64), 62 (1.5-64) and 34 (0.94-64) mg.ml-1, respectively, and 32 mg.ml-1 for each bradykinin challenge (range: 0.015-32, 0.088-32 and 0.033-32). There were no significant differences between study days for PC15FEV1 histamine or bradykinin for the whole group, the infected subjects, those with clinical colds or for those infected with either RV subtype. There was no significant change in mean daily PEF after viral infection. We conclude that airways reactivity to histamine and bradykinin is unchanged after experimental RV infection in normal volunteers.


This article has been cited by other articles:


Home page
Am. J. Respir. Crit. Care Med.Home page
H. E. FLEMING, F. F. LITTLE, D. SCHNURR, P. C. AVILA, H. WONG, J. LIU, S. YAGI, and H. A. BOUSHEY
Rhinovirus-16 Colds in Healthy and in Asthmatic Subjects . Similar Changes in Upper and Lower Airways
Am. J. Respir. Crit. Care Med., July 1, 1999; 160(1): 100 - 108.
[Abstract] [Full Text]


Home page
Clin. Microbiol. Rev.Home page
J. E. Gern and W. W. Busse
Association of Rhinovirus Infections with Asthma
Clin. Microbiol. Rev., January 1, 1999; 12(1): 9 - 18.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
G. FOLKERTS, W. W. BUSSE, F. P. NIJKAMP, R. SORKNESS, and J. E. GERN
Virus-induced Airway Hyperresponsiveness and Asthma
Am. J. Respir. Crit. Care Med., June 1, 1998; 157(6): 1708 - 1720.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1992 by the European Respiratory Society.